Literature DB >> 10226067

A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.

M Baldini1, I C Lohman, M Halonen, R P Erickson, P G Holt, F D Martinez.   

Abstract

Total serum immunoglobulin (Ig)E levels are genetically regulated, but the mechanism of inheritance is not well understood. Cytokines produced by T-helper (Th)1 and Th2 lymphocytes control IgE synthesis. Bacterial antigens may favor the development of Th1 cells from naive CD4-positive T cells through a CD14-dependent pathway. CD14 is constitutively expressed on the surface of monocytes and macrophages, and is also present in serum in a soluble form (sCD14). The CD14 gene maps to chromosome 5q31.1, a candidate region for loci regulating total serum IgE. We hypothesized that genetic variants in the CD14 gene could influence Th-cell differentiation and thus total serum IgE. We identified a C-to-T transition at base pair -159 from the major transcription start site (CD14/-159). Among 481 children recruited from a general population sample, frequency of allele C was 51.4%. TT homozygotes had significantly higher sCD14 levels than did carriers of both the CC and CT genotypes (P = 0.01). TT homozygotes also had significantly lower levels of IgE than did carriers of the other two genotypes, but differences were significant only among children who were skin test-positive to local aeroallergens (P = 0.004). There was no association between CD14/-159 and either interleukin (IL)-4 or interferon (IFN)-gamma responses by peripheral blood mononuclear cells. However, IFN-gamma and IL-4 responses were positively and negatively correlated, respectively, with serum sCD14 levels. We conclude that CD14/-159 plays a significant role in regulating serum sCD14 levels and total serum IgE levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226067     DOI: 10.1165/ajrcmb.20.5.3494

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  168 in total

1.  A second-generation genomewide screen for asthma-susceptibility alleles in a founder population.

Authors:  C Ober; A Tsalenko; R Parry; N J Cox
Journal:  Am J Hum Genet       Date:  2000-10-05       Impact factor: 11.025

Review 2.  Does environmental endotoxin exposure prevent asthma?

Authors:  J Douwes; N Pearce; D Heederik
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations.

Authors:  Mamta Sharma; Jyotsna Batra; U Mabalirajan; Sangeeta Goswami; Dipyaman Ganguly; Brajen Lahkar; N K Bhatia; Amrendra Kumar; Balaram Ghosh
Journal:  Immunogenetics       Date:  2004-09-18       Impact factor: 2.846

Review 4.  The 'hygiene hypothesis' for autoimmune and allergic diseases: an update.

Authors:  H Okada; C Kuhn; H Feillet; J-F Bach
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

5.  No Association Between -159C/T Polymorphism of the CD14 Gene and Asthma Risk: a Meta-Analysis of 36 Case-Control Studies.

Authors:  Rui Zhang; Rui Deng; He Li; Hong Chen
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  Critical investigation of the CD14 promoter polymorphism: lack of a role for in vitro cytokine response and membrane CD14 expression.

Authors:  Sonja von Aulock; Jan Rupp; Katja Gueinzius; Matthias Maass; Corinna Hermann
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

Review 7.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

8.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

9.  Suppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccine.

Authors:  J W Wells; K Choy; C M Lloyd; A Noble
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

10.  Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures.

Authors:  K Anttonen; A Orpana; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.